One of Baltimore’s largest biotechnology companies has hired a new CEO as it pushes toward a wider commercial launch of its early cancer detection device. Delfi Diagnostics announced on Friday that Susan Tousi will take over as CEO, replacing founder Victor Velculescu. Velculescu will remain a member of the company’s board of directors.
Baltimore biotech backed by more than $300M in funding names new CEO
January 8, 2024